Company Filing History:
Years Active: 2018
Title: Innovations in Glaucoma Treatment by Beth Friedland
Introduction
Beth Friedland is an accomplished inventor based in Raleigh, NC, who has made significant contributions to the field of ophthalmology. She holds a patent that addresses a critical issue in eye health, specifically targeting open-angle glaucoma. Her innovative approach aims to reduce intraocular pressure, which is essential for preventing and treating this common eye condition.
Latest Patents
Beth Friedland's notable patent is titled "Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma." This invention involves applying heat to the trabecular meshwork in a patient's eye without damaging the proteins within it. By doing so, the method effectively relaxes or loosens protein clogs that obstruct the outflow of aqueous humor, thereby lowering intraocular pressure and mitigating the risk of glaucoma.
Career Highlights
Throughout her career, Beth has demonstrated a commitment to advancing medical technology. Her work at Tearscience, Inc. has positioned her as a leader in the development of innovative solutions for eye care. With her expertise, she has contributed to the understanding and treatment of ocular hypertension, enhancing patient outcomes.
Collaborations
Beth Friedland has collaborated with esteemed colleagues, including Donald R. Korb and Steve Grenon. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of ophthalmology.
Conclusion
Beth Friedland's contributions to glaucoma treatment through her innovative patent exemplify her dedication to improving eye health. Her work not only addresses a significant medical challenge but also showcases the potential of innovation in the healthcare sector.